Related Experiment Video
Updated: Aug 11, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
Hospitalization for worsening chronic heart failure
Leonardo De Luca1, Mihai Gheorghiade
1Department of Cardiovascular and Respiratory Sciences, La Sapienza University, Rome, Italy. leodeluca@virgilio.it
Insights
Heart failure (HF) admissions are high, with 30-60% readmission rates. This review focuses on worsening chronic heart failure, covering its epidemiology, prognosis, pathophysiology, and treatment.
Area of Science:
- Cardiology
- Internal Medicine
- Public Health
Background:
- Heart failure (HF) admissions approach 1 million annually in the US.
- HF is the leading diagnosis in the Medicare system.
- High readmission rates (30-60% within 3-6 months) are observed even in stable patients.
Purpose of the Study:
- To review the epidemiology, prognosis, pathophysiology, and pharmacological treatment of worsening chronic heart failure.
- To provide insights into managing the most common HF patient category (90% of admissions).
Main Methods:
- Literature review focusing on worsening chronic heart failure.
- Analysis of epidemiological data, prognostic factors, and current treatment strategies.
Main Results:
- Worsening chronic HF constitutes 90% of HF hospitalizations.
- Significant readmission rates highlight the need for effective management strategies.
- Understanding pathophysiology is crucial for targeted pharmacological interventions.
Conclusions:
- Worsening chronic HF is a major healthcare burden.
- Effective management requires a comprehensive approach addressing epidemiology, prognosis, pathophysiology, and treatment.
- Further research into optimizing pharmacological therapies is warranted.
Abstract:
The total number of admissions for heart failure (HF) in the United States is approaching 1 million/year. HF is the number one volume diagnosis in the Medicare health system. Readmission rates are as high as 30 to 60% within 3 to 6 months after discharge even in patients without renal failure, low blood pressure or significant arrhythmias. Patients admitted with HF can be classified into three categories: new-onset HF (5% of total admissions), end-stage or refractory HF (5%), and worsening chronic HF (90%). This review will focus on the epidemiology, prognosis, pathophysiology and pharmacological treatment of patients hospitalized for worsening chronic HF.
More Related Videos
07:41Induction and Phenotyping of Acute Right Heart Failure in a Large Animal Model of Chronic Thromboembolic Pulmonary Hypertension
Published on: March 17, 2022
05:16Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
Related Concept Videos
Heart Failure III: Clinical Manifestations
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure V: Medical Management
Heart Failure VI: Adjunct Therapies
Heart Failure VII: Nursing Interventions
Cardiomyopathy V: Interprofessional Care